|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade receivables, net of allowance of $0 and $0, respectively | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Prepaid and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, Plant and Equipment: | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Property, Plant and Equipment, net | ||||||||||||||||||||
| Other Assets: | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Patents, net of accumulated amortization of $141,872 and $141,189 respectively | ||||||||||||||||||||
| Equity method investment | ||||||||||||||||||||
| Other investment | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Related party payables | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Accrued payroll | ||||||||||||||||||||
| Accrued professional services fees | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Current portion of operating lease liability | ||||||||||||||||||||
| Conversions payable | ||||||||||||||||||||
| Cash payable | ||||||||||||||||||||
| Current portion of convertible notes, net | ||||||||||||||||||||
| Bridge loan | ||||||||||||||||||||
| Other payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-Term Liabilities: | ||||||||||||||||||||
| Non-current operating lease liabilities | ||||||||||||||||||||
| Accrued warranty liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity: | ||||||||||||||||||||
| Series A preferred stock, $.0001 par value; 750,000 shares authorized; 48,100 and 48,100 shares issued and outstanding, respectively ($1,020,923 and $996,739 Liquidation Preference, respectively) | ||||||||||||||||||||
| Common stock, $0.0001 par value, 200,000,000 authorized; 9,816,431 and 4,662,208 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity | ||||||||||||||||||||
Loading...
